Reply to Cevik et al by Rowland-Jones, S, Yindom, L, Ferrand, R

HIV status disclosure to perinatally-infected adolescents in Zimbabwe: a qualitative study of adolescent and healthcare worker perspectives by Kidia, K, Mupambireyi, Z, Cluver, L, Ndhlovu, C, Borok, M, Ferrand, R

HLA Correlates of Long-Term Survival in Vertically Infected HIV-1-Positive Adolescents in Harare, Zimbabwe. by Shepherd, B, Ferrand, R, Munyati, S, Folkard, S, Boyd, K, Bandason, T, Jallow, S, Rowland-Jones, S, Yindom, L

CD4+ cell count recovery following initiation of HIV antiretroviral therapy in older childhood and adolescence by Simms, V, Rylance, S, Bandason, T, Dauya, E, McHugh, G, Munyati, S, Mujuru, H, Rowland-Jones, S, Weiss, H, Ferrand, R

Chronic lung disease in HIV-infected children established on antiretroviral therapy by Rylance, J, Mchugh, G, Metcalfe, J, Mujuru, H, Nathoo, K, Wilmore, S, Rowland-Jones, S, Majonga, E, Kranzer, K, Ferrand, R

Unexpectedly high prevalence of cytomegalovirus DNAemia in older children and adolescents with perinatally acquired human immunodeficiency virus infection by Yindom, L, Simms, V, Majonga, E, McHugh, G, Dauya, E, Bandason, T, Vincon, H, Rylance, J, Munyati, S, Ferrand, R, Rowland-Jones, S

Azithromycin versus placebo for the treatment of HIV-associated chronic lung disease in children and adolescents (BREATHE trial): study protocol for a randomised controlled trial. by Gonzalez-Martinez, C, Kranzer, K, McHugh, G, Corbett, E, Mujuru, H, Nicol, M, Rowland-Jones, S, Rehman, A, Gutteberg, T, Flaegstad, T, Odland, J, Ferrand, R, BREATHE study team